Exploiting another anti-EpCAM mAb, HEA125, and toxic α-amanitin, a specific inhibitor of RNA polymerase II that is closely related to CRC, Liu et al. designed ama–HEA125 via conjugation of the HEA125 mAb to α-amanitin. The gene discussed is EPCAM; the disease is colorectal carcinoma.